CSMD2 and cancer: Most of these genes influence patient survival via their effects on proliferation (KCNH8, LUCAT1, and DLEU1), metastasis (MAOA, LINC01612, and LINC00578), invasion (LINC02163 and CENPI), progression (TRIM24, ST8SIA4, KPNA2, and CSMD2), drug resistance (UGT8, SLC22A3, and CYSLTR1), and immunity and immune cells (DTX4, CHSY3, and CCRL2), and nearby genes are involved in several cancer processes (Table S34).